← Back to Influence Map
Entity DossierOrganization
MERCK & CO INC
pharmaceuticalspharma
Tracked direct giving
$0
LDA reported lobbying spend
$10,960,000
Connections
18
Federal Contracts and Awards
Federal obligations, FY2015–FY2025
$5.08B
Totals are complete for each fiscal year, as reported by USASpending.gov for MERCK & CO., INC. and its subsidiaries. Window matches the election cycles this tracker holds FEC data for.
| Fiscal year | Contract obligations | Total obligated | Top awarding agencies |
|---|---|---|---|
| FY2025selected | $2.88B | $2.88B | Health and Human Services $2.88B · Veterans Affairs $1.3M · Interior $1.1M |
| FY2024 | $2.20B | $2.20B | Health and Human Services $2.20B · Veterans Affairs $689K · Interior $465K |
| FY2023 | $0 | $0 | — |
| FY2022 | $0 | $0 | — |
| FY2021 | $0 | $0 | — |
| FY2020 | $0 | $0 | — |
| FY2019 | $0 | $0 | — |
| FY2018 | $0 | $0 | — |
| FY2017 | $0 | $0 | — |
| FY2016 | $0 | $0 | — |
| FY2015 | $0 | $0 | — |
Largest contract actions, FY2025
Showing 5 of 5 actions of $250K or more on file here ($5.2M of $2.88B obligated)
| Action date | Obligation | Agency | Award | Description | |
|---|---|---|---|---|---|
| Aug 6, 2025 | $2.8M | Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | 75A50124C00057mod P00001 | ERVEBO PROCUREMENT | |
| Aug 12, 2025 | $1.3M | Health and Human ServicesCenters for Disease Control and Prevention | 75D30121F00001mod P00016 | ADMIN MOD - BORROW / RETURN OF STOCKPILE VACCINE DOSES | |
| Jun 30, 2025 | $500K | InteriorU.S. Fish and Wildlife Service | 140F1G25P0040 | WA COLUMBIA RIV FPO PIT TAGS URGENT | |
| Aug 15, 2025 | $297K | InteriorU.S. Fish and Wildlife Service | 140F1G25P0056 | OR-KLAMATH FALLS FWO-BIOMARK PURCH REQUE | |
| Oct 1, 2024 | $260K | Veterans Affairs | 36C26025F0023 | WELIREG BULK |
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MMMMedicare/Medicaid
$26.0MHCRHealth Issues
$25.4MTAXTaxation/Internal Revenue Code
$24.0MANIAnimals
$14.9MTRDTrade
$1.7MCPTCopyright/Patent/Trademark
$560KBUDBudget/Appropriations
$440KPHAPharmacy
$200KHOMHousing
$50KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$21.9M
WILLIAMS AND JENSEN, PLLC$700K
W STRATEGIES, LLC$700K
AVENUE SOLUTIONS$700K
TIBER CREEK GROUP$650K
CROSSROADS STRATEGIES, LLC$560K
TODD STRATEGY GROUP$480K
THE NICKLES GROUP, LLC$290K
Harbinger Strategies$200K
BROWNSTEIN HYATT FARBER SCHRECK, LLP$200K
Bills Referenced in Lobbying Filings
march-inPBM
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | W STRATEGIES, LLC | Hired W STRATEGIES, LLC to lobby on Pharmaceuticals | Source |
| Lobbied on | CLARITY Act, Digital Asset Market Clarity Act | LDA filing: lobbied on CLARITY Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,190,000 | Source |
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $40,000 | Source |
| Retained | CROSSROADS STRATEGIES, LLC | Hired CROSSROADS STRATEGIES, LLC to lobby on NIH March-In Rights | Source |
| Retained | TIBER CREEK GROUP | Hired TIBER CREEK GROUP to lobby on Pharmaceuticals | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,930,000 | Source |
| Contracted with | Department of Health and Human Services | Merck received award from Department of Health and Human Services | Source |
| Contracted with | Department of Defense | Merck received award from Department of Defense | Source |
| Retained | THE NICKLES GROUP, LLC | Hired THE NICKLES GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025) | Source |
| Retained | AVENUE SOLUTIONS | Hired AVENUE SOLUTIONS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | Harbinger Strategies | Hired HARBINGER STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025) | Source |
| Retained | TODD STRATEGY GROUP | Hired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | WILLIAMS AND JENSEN, PLLC | Hired WILLIAMS AND JENSEN, PLLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Hired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Affiliated with | Alfred Lumsdaine | MSD (Merck Sharp & Dohme) is the international name for Merck & Co. | Source |
| Affiliated with | Tony Ramsden | MSD (Merck Sharp & Dohme) is the international name for Merck & Co. | Source |
| Affiliated with | Margaret Amsden | MSD (Merck Sharp & Dohme) is the international name for Merck & Co. | Source |
| Has as instrument | Merck & Co. Inc. PAC | Separate segregated fund (corporate PAC) whose connected organization is MERCK & CO., INC., per FEC records. | Source |